Elisa Attkisson

592 total citations
7 papers, 438 citations indexed

About

Elisa Attkisson is a scholar working on Molecular Biology, Hematology and Epidemiology. According to data from OpenAlex, Elisa Attkisson has authored 7 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Hematology and 2 papers in Epidemiology. Recurrent topics in Elisa Attkisson's work include Histone Deacetylase Inhibitors Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). Elisa Attkisson is often cited by papers focused on Histone Deacetylase Inhibitors Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). Elisa Attkisson collaborates with scholars based in United States and France. Elisa Attkisson's co-authors include Steven Grant, D. Clive Williams, Mandy Mayo Aust, Andrea Ferreira‐Gonzalez, Mohamed Rahmani, Laxmikant S. Deshpande, Sompong Sombati, Robert J. DeLorenzo, Ali Mian and Robert E. Blair and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Elisa Attkisson

7 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisa Attkisson United States	6	287	107	72	70	53	7	438
Mitsumasa Watanabe Japan	13	438 1.5×	70 0.7×	16 0.2×	82 1.2×	39 0.7×	43	683
Takashi Shimada Japan	10	149 0.5×	41 0.4×	51 0.7×	24 0.3×	49 0.9×	36	455
Changyong Hu Singapore	10	151 0.5×	29 0.3×	32 0.4×	51 0.7×	25 0.5×	17	360
Kristina M. Fetalvero United States	10	288 1.0×	26 0.2×	44 0.6×	25 0.4×	67 1.3×	12	575
Silvia Sostegni Australia	5	132 0.5×	77 0.7×	53 0.7×	35 0.5×	9 0.2×	6	392
Wangwei Cai China	13	239 0.8×	23 0.2×	27 0.4×	20 0.3×	74 1.4×	41	507
M. Girós Spain	16	556 1.9×	21 0.2×	23 0.3×	85 1.2×	46 0.9×	40	749
Jack J. Huizenga Canada	8	280 1.0×	18 0.2×	60 0.8×	20 0.3×	15 0.3×	9	772
Julian C. Assmann Germany	8	147 0.5×	34 0.3×	18 0.3×	45 0.6×	29 0.5×	11	371
Marie‐Thérèse Schouft France	11	102 0.4×	23 0.2×	49 0.7×	23 0.3×	32 0.6×	13	417

Countries citing papers authored by Elisa Attkisson

Since Specialization

Citations

This map shows the geographic impact of Elisa Attkisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Attkisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Attkisson more than expected).

Fields of papers citing papers by Elisa Attkisson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Attkisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Attkisson. The network helps show where Elisa Attkisson may publish in the future.

Co-authorship network of co-authors of Elisa Attkisson

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Attkisson. A scholar is included among the top collaborators of Elisa Attkisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Attkisson. Elisa Attkisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Rahmani, Mohamed, Mandy Mayo Aust, Elisa Attkisson, et al.. (2012). Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances PI3K Inhibition-Induced Apoptosis in Human Myeloid Leukemia Cells through a GSK3- and Bim-Dependent Mechanism. Cancer Research. 73(4). 1340–1351. 128 indexed citations

Dasmahapatra, Girija, Hiral Patel, Tri Q. Nguyen, Elisa Attkisson, & Steven Grant. (2012). PLK1 Inhibitors Synergistically Potentiate HDAC Inhibitor Lethality in Imatinib Mesylate–Sensitive or –Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo. Clinical Cancer Research. 19(2). 404–414. 22 indexed citations

Rahmani, Mohamed, Mandy Mayo Aust, Elisa Attkisson, et al.. (2012). Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process. Blood. 119(25). 6089–6098. 90 indexed citations

Nguyen, Tri, Yun Dai, Elisa Attkisson, et al.. (2011). HDAC Inhibitors Potentiate the Activity of the BCR/ABL Kinase Inhibitor KW-2449 in Imatinib-Sensitive or -Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo. Clinical Cancer Research. 17(10). 3219–3232. 70 indexed citations

Nguyen, Tri K., Elisa Attkisson, Yun Dai, et al.. (2011). Abstract 2572: The histone deacetylase inhibitors (HDACIs) vorinostat and entinostat interact synergistically with the Bcr/Abl, FLT3, and aurora kinase inhibitor KW-2449 to induce apoptosis in imatininb mesylate (IM)-sensitive and -resistant CML and ALL cells in vitro and in vivo. Cancer Research. 71(8_Supplement). 2572–2572. 1 indexed citations

Deshpande, Laxmikant S., Ali Mian, Robert E. Blair, et al.. (2008). Time course and mechanism of hippocampal neuronal death in an in vitro model of status epilepticus: Role of NMDA receptor activation and NMDA dependent calcium entry. European Journal of Pharmacology. 583(1). 73–83. 73 indexed citations

Deshpande, Laxmikant S., David Sun, Sompong Sombati, et al.. (2008). Alterations in neuronal calcium levels are associated with cognitive deficits after traumatic brain injury. Neuroscience Letters. 441(1). 115–119. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact